| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441626 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
Denosumab was superior to ZA in preventing SREs in patients with bone metastases from advanced cancer, regardless of ECOG PS, bone metastasis number, baseline visceral metastasis presence/absence, and uNTx level.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
A. Lipton, K. Fizazi, A.T. Stopeck, D.H. Henry, M.R. Smith, N. Shore, M. Martin, S. Vadhan-Raj, J.E. Brown, G.E. Richardson, F. Saad, D.A. Yardley, K. Zhou, A. Balakumaran, A. Braun,